This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This AKAP8L antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 485-512 amino acids from the C-terminal region of human AKAP8L.
AKAP8L
Reaktivität: Human
IHC, IF (p)
Wirt: Kaninchen
Polyclonal
unconjugated
Applikationshinweise
For WB starting dilution is: 1:1000
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
0.5 mg/mL
Buffer
Supplied in PBS with 0.09 % (W/V) sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Target
AKAP8L
(A Kinase (PRKA) Anchor Protein 8-Like (AKAP8L))
HA95 antikoerper, HAP95 antikoerper, NAKAP antikoerper, NAKAP95 antikoerper, Nakap95 antikoerper, zgc:85966 antikoerper, AKAP8L antikoerper, A-kinase anchoring protein 8 like antikoerper, A kinase (PRKA) anchor protein 8-like antikoerper, A-kinase anchoring protein 8 like L homeolog antikoerper, AKAP8L antikoerper, Akap8l antikoerper, akap8l antikoerper, akap8l.L antikoerper
Hintergrund
AKAP8L could play a role in constitutive transport element (CTE)-mediated gene expression. Does not seem to be implicated in the binding of regulatory subunit II of PKA. May be involved in nuclear envelope breakdown and chromatin condensation. May regulate the initiation phase of DNA replication when associated with TMPO-beta.